The FDA will begin promoting computer-based and lab-grown drug testing models to reduce the cost, time, and ethical burden of drug testing.

This is a groundbreaking step toward advancing public health by using more effective and human-relevant methods instead of ...

Interested in finding a better way to develop drugs to treat amyotrophic lateral sclerosis (ALS), Northeastern researcher ...

Revelations about Meta's secret tests highlight how valuable training data is for AI model development, and suggest a way for ...

The U.S. Food and Drug Administration (FDA) has unveiled a strategic roadmap to reduce reliance on animal testing in ...

Based on Certara’s extensive experience working with FDA, EMA, and other major health authorities, the Non-Animal Navigator is a flexible solution that ensures each client’s development program is ...

Schrodinger (SDGR) said it supports the FDA’s plan to reduce, refine or potentially replace current animal testing requirements with new ...

Recuresion Pharma (RXRX) stock and other AI-driven biotechs surge as FDA embraces computational models over animal testing ...

The initiative, which will start with monoclonal antibodies, is the first big regulatory shift from the FDA since Martin ...

The FDA announced a shift away from animal testing for drug approval, citing advanced alternatives like AI and organoids ...

The Food and Drug Administration (FDA) announced Thursday it plans to phase out animal testing requirements for biological ...